Tuesday, June 30, 2009

New Cancer Drugs: Most Not Worth the Cost?

Cancer drugs with limited benefits shouldn't be developed if they cost more than $20,000, say authors of a new study.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)